Evidence map›Paper›PMID 35658059›Full record

Trial reportPloS one2022

Cingulate transcranial direct current stimulation in adults with HIV.

Xiong Jiang, Sophia Dahmani, Margarita Bronshteyn, Fan Nils Yang, John Paul Ryan, R Craig Gallagher, Srikanth R Damera, Princy N Kumar, David J Moore, Ronald J Ellis and 1 more

Erratum issuedOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xiong JiangDepartment of Neuroscience, Georgetown University Medical Center, Washington, DC, United States of America.ORCID 0000-0001-7054-1556
Sophia DahmaniDepartment of Neuroscience, Georgetown University Medical Center, Washington, DC, United States of America.
Margarita BronshteynDepartment of Neuroscience, Georgetown University Medical Center, Washington, DC, United States of America.
Fan Nils YangDepartment of Neuroscience, Georgetown University Medical Center, Washington, DC, United States of America.
John Paul RyanDepartment of Neuroscience, Georgetown University Medical Center, Washington, DC, United States of America.
R Craig GallagherDepartment of Neuroscience, Georgetown University Medical Center, Washington, DC, United States of America.
Srikanth R DameraDepartment of Neuroscience, Georgetown University Medical Center, Washington, DC, United States of America.
Princy N KumarDepartment of Medicine, Georgetown University Medical Center, Washington, DC, United States of America.
David J MooreDepartment of Psychiatry, University of California, San Diego, CA, United States of America.ORCID 0000-0001-9699-318X
Ronald J EllisDepartment of Psychiatry, University of California, San Diego, CA, United States of America.ORCID 0000-0003-4931-752X
Peter E TurkeltaubDepartment of Neurology and Center for Brain Plasticity and Recovery, Georgetown University Medical Center, Washington, DC, United States of America.
Georgetown University · USUniversity of California San Diego · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
An advanced functional MRI study of frontostriatal injury in adults with HIVR01NS124422 · NINDS · GEORGETOWN UNIVERSITY · PI Xiong Jiang · 2022 to 2026
$2.4M
A Novel FMRI Biomarker of Asymptomatic HIV-Associated Neurocognitive DisordersR01MH108466 · NIMH · GEORGETOWN UNIVERSITY · PI JIANG, XIONG · 2015 to 2019
$2.1M
Prisma Upgrade for a Siemens 3T MRI ScannerS10OD023561 · OD · GEORGETOWN UNIVERSITY · PI VANMETER, ASHLEY S · 2017 to 2017
$1.3M
An advanced functional MRI study of frontostriatal injury in adults with HIVR56NS124422 · NINDS · GEORGETOWN UNIVERSITY · PI JIANG, XIONG · 2021 to 2021
$586k
NIH HHS S10 OD023561NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH108466NINDS NIH HHS R01 NS124422NINDS NIH HHS R56 NS124422
6 · The paper itself

Abstract

backgroundNeuronal dysfunction plays an important role in the high prevalence of HIV-associated neurocognitive disorders (HAND) in people with HIV (PWH). Transcranial direct current stimulation (tDCS)-with its capability to improve neuronal function-may have the potential to serve as an alternative therapeutic approach for HAND. Brain imaging and neurobehavioral studies provide converging evidence that injury to the anterior cingulate cortex (ACC) is highly prevalent and contributes to HAND in PWH, suggesting that ACC may serve as a potential neuromodulation target for HAND. Here we conducted a randomized, double-blind, placebo-controlled, partial crossover pilot study to test the safety, tolerability, and potential efficacy of anodal tDCS over cingulate cortex in adults with HIV, with a focus on the dorsal ACC (dACC).

methodsEleven PWH (47-69 years old, 2 females, 100% African Americans, disease duration 16-36 years) participated in the study, which had two phases, Phase 1 and Phase 2. During Phase 1, participants were randomized to receive ten sessions of sham (n = 4) or cingulate tDCS (n = 7) over the course of 2-3 weeks. Treatment assignments were unknown to the participants and the technicians. Neuropsychology and MRI data were collected from four additional study visits to assess treatment effects, including one baseline visit (BL, prior to treatment) and three follow-up visits (FU1, FU2, and FU3, approximately 1 week, 3 weeks, and 3 months after treatment, respectively). Treatment assignment was unblinded after FU3. Participants in the sham group repeated the study with open-label cingulate tDCS during Phase 2. Statistical analysis was limited to data from Phase 1.

resultsCompared to sham tDCS, cingulate tDCS led to a decrease in Perseverative Errors in Wisconsin Card Sorting Test (WCST), but not Non-Perseverative Errors, as well as a decrease in the ratio score of Trail Making Test-Part B (TMT-B) to TMT-Part A (TMT-A). Seed-to-voxel analysis with resting state functional MRI data revealed an increase in functional connectivity between the bilateral dACC and a cluster in the right dorsal striatum after cingulate tDCS. There were no differences in self-reported discomfort ratings between sham and cingulate tDCS.

conclusionsCingulate tDCS is safe and well-tolerated in PWH, and may have the potential to improve cognitive performance and brain function. A future study with a larger sample is warranted.

Indexed as

HIV InfectionsTranscranial Direct Current StimulationAdultAgedDouble-Blind MethodFemaleGyrus CinguliHumansMiddle AgedPilot Projects

Identifiers

PMID35658059
PMCPMC9165807
OpenAlexW4281682664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.